Earnings

The gain came from program increases in aerospace and modernization, plus a $128.9 million increase from discrete activities supporting a national security mission. Revenue from U.S. programs rose by $209.4 million, or 31% by management's account, while Asia Pacific revenue rose 8%. Middle East …

Adjusted EBITDA climbed to $151 million from $97 million. Revenues excluding reimbursable items rose to $556 million from $502 million, mainly because three drillships started new contracts during the second and third quarters after idle periods, and another began work at a higher day …

The company attributed the growth mainly to its cystic fibrosis medicines, including new patient starts on ALYFTREK and higher realized net prices, along with contributions from CASGEVY, JOURNAVX and PALSONIFY. Reimbursement for ALYFTREK now covers 32 countries after seven were added in the quarter.

Consolidated net income was $300 million, compared with a net loss of $197 million in the prior-year quarter, which included a $360 million impairment. Net income attributable to Viper was $140 million, or $0.72 per diluted Class A share, versus a loss of $0.52 …

Oil revenue rose 19% to $76.5 million andNatural Gasrevenue rose 113% to $6.4 million. The average realized price before hedging rose 33% to $53.59 per barrel of oil equivalent, which added $22.1 million of revenue, while a 7% drop in volumes subtracted $6.6 million. …

Vornado is a fully integrated REIT that owns and operates office, retail and residential properties, with about 90% of its NOI at share coming from the New York City area. Its in-service portfolio spans 34.0 million square feet, or 26.5 million at its share.

After-tax adjusted operating earnings were $240 million, or $2.60 per diluted share, against $239 million, or $2.45. Higher earnings in Retirement and Employee Benefits were largely offset by weakerInvestmentCapitalincome in Investment Management and about $25 million of pre-tax severance expense.